Global Aortic Endograft Market Report 2024: Growth Rate, Major Segments And Regions

saikiran TBRC

Global Aortic Endograft Market Report 2024: Growth Rate, Major Segments And Regions

The Aortic Endograft Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Aortic Endograft Market:

https://www.thebusinessresearchcompany.com/report/aortic-endograft-global-market-report

According to The Business Research Company’s Aortic Endograft Global Market Report 2024, The aortic endograft market size is expected to see strong growth in the next few years. It will grow to $4.08 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increasing prevalence of abdominal aortic aneurysmsm, growing preference for minimally invasive endovascular procedures, rising geriatric population, advancements in stent-graft materials and configurations, introduction of new stent-graft products. Major trends in the forecast period include adoption of endovascular abdominal aortic aneurysm (AAA) repair devices, effectiveness of unibody and non-unibody aortic stent, product innovation.

The growing prevalence of aortic aneurysms is expected to propel the growth of the aortic endograft market going forward. An aortic aneurysm is a localized and abnormal dilation or bulging of the aorta, which is the largest artery in the human body. Aortic endografts are used to treat aortic aneurysms because they are less invasive than traditional open surgery. A fabric-covered metal or polymer device is inserted through a catheter, strengthening weak aortic walls and lowering the risk of rupture. For instance, in February 2023, according to Government Digital Service, a UK-based public sector information website, around 274,800 men were offered screening, with 79.0% receiving a conclusive screen and 1,794 aneurysms being found April 2021 to March 2022. Therefore, the growing prevalence of aortic aneurysms is driving the growth of the aortic aneurysm market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=13784&type=smp

The aortic endograft market covered in this report is segmented –

1) By Product: Abdominal Aortic Grafts, Thoracic Aortic Grafts

2) By Material: Metallic Endografts, Polymeric Endografts

3) By Procedure: Open Surgical Repair, Endovascular Aneurysm Repair (EVAR)

4) By End User: Hospitals, Ambulatory Surgical Centers

Major companies operating in the aortic endograft market are developing innovative solutions, such as the castor-branched aortic stent graft system, to gain a competitive edge in the market. The castor-branched aortic stent graft system is a medical device used for minimally invasive repair of the aorta and aortic arch, particularly in cases of Stanford type B aortic dissection (TBAD). For instance, in December 2021, Shanghai MicroPort Endovascular MedTech Group Co. Ltd., a China-based manufacturer of aortic and peripheral vascular intervention devices, launched the CastorTM Branched Aortic Stent-Graft System (CastorTM). The world's first stent-graft device for simultaneous aortic and aortic arch repair with minimally invasive therapy. The distinctive unibody design of this device may conform to diverse arch anatomies and provide one-time access and release. This feature guarantees the safe and easy reconstruction of the left subclavian artery while also mitigating the risk of endoleaks and promoting long-term stability.

The aortic endograft market report table of contents includes:

1. Executive Summary

2.Aortic Endograft Market Characteristics

3.Aortic Endograft Market Trends And Strategies

4.Aortic Endograft Market analysis

5.Aortic Endograft Market Size And Growth

6.Aortic Endograft Segmentation

7.Aortic Endograft Regional And Country Analysis

27.Aortic Endograft Competitive Landscape And Company Profiles

28.Aortic Endograft Key Mergers And Acquisitions

29.Aortic Endograft Future Outlook and Potential Analysis

TOP MAJOR PLAYERS:

Cardinal Health Inc.
Abbott Laboratories
Medtronic Plc
Becton
Dickinson and Company

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

saikiran TBRC

Aortic Aneurysm Market Size, Share, Regional Overview and Global Forecast to 2030

kashish Singh 2023-05-04

Get more information on "Global Aortic Aneurysm Market Research Report" by requesting FREE Sample Copy at https://www. Additionally, these tools also give an inclusive assessment of each segment in the global market of aortic aneurysm. Browse Global Aortic Aneurysm Market Research Report with detailed TOC at https://www. By TypeThoracic Aortic Aneurysm (TAA)Abdominal Aortic Aneurysm (AAA)By TreatmentOpen Surgical Repair (OSR)Endovascular Aneurysm Repair (EVAR)By ProductStent GraftsCathetersBy End UserHospitalsAmbulatory Surgery CentersClinicsRegional AnalysisThis section covers the regional outlook, which accentuates current and future demand for the Aortic Aneurysm market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Purchase Complete Global Aortic Aneurysm Market Research Report at https://www.

Aortic Aneurysm Market Analysis 2023 : By Growth Opportunities, Key Dynamics, Recent Developments and Future Forecast To 2032 | AbbVie Inc., Cardiatis SA, Cook Medical Inc., Endologix LLC, W L Gore & Associates Inc.

Vivek vishwakarma 2023-07-18

The Aortic Aneurysm Global Market Report 2023 evaluates aortic aneurysm market size, growth rate, drivers, trends, and major companies. id=10559&type=smpThe global aortic aneurysm market size is expected to grow from $3. The global aortic aneurysm market size is expected to reach $4. The aortic aneurysm market segments in the report are:1) By Type: Thoracic Aortic Aneurysm (TAA), Abdominal Aortic Aneurysm (AAA)2) By Treatment: Open Surgical Repair (OSR), Endovascular Aneurysm Repair (EVAR)3) By End User: Hospitals And Clinics, Ambulatory Surgery Centers (ASCs), Other End UsersNorth America was the largest region in the aortic aneurysm market in 2022. Get More Information On The Aortic Aneurysm Market Report:https://www.

Aortic Stenosis Market is Estimated To Witness High Growth Owing To Rapidly Increasing Adoption of Transcatheter Aortic Valve Replacement Procedures

kiran gire 2023-12-01

The global aortic stenosis market is expected to witness high growth, exhibiting a CAGR of 15% over the forecast period, due to increasing Aortic Stenosis Market is Estimated To Witness High Growth Owing To Rapidly Increasing Adoption of Transcatheter Aortic Valve Replacement ProceduresThe Aortic Stenosis Market is estimated to be valued at US$ 14. Treatment options include surgical aortic valve replacement using either mechanical or biological valves, and minimally-invasive transcatheter aortic valve replacement (TAVR) procedures. Traditionally, surgical aortic valve replacement (SAVR) was the standard treatment for severe aortic stenosis. Threat of new substitutes: No major substitute treatments currently available pose a threat to devices and medications used for aortic valve replacement. Europe accounts for a significant share due to rise in adoption of transcatheter aortic valve replacement (TAVR) procedures.

Aortic Stenosis Market: Assessing Impact of Key Market Players and Partnerships

Roger 2024-04-01

The aortic stenosis market comprises products such as bioprosthetic heart valves, transcatheter heart valves, and other devices that are used in minimally invasive procedures for the treatment of aortic stenosis. Key TakeawaysKey players operating in the aortic stenosis market are Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, CryoLife, Inc. Impact of COVID-19 on Aortic Stenosis Market Growth:The COVID-19 pandemic significantly impacted the growth of the aortic stenosis market in 2020. North America Accounts for Highest Value Share in Aortic Stenosis Market:North America currently dominates the aortic stenosis market and accounts for the highest value share. Europe Captures Second Largest Value Share in Aortic Stenosis Market:Europe captures the second largest value share in the global aortic stenosis market.

Aortic Stenosis Market Estimated to Witness High Growth Owing to Increasing Geriatric Population

Omkar Patel 2023-12-21

Transcatheter aortic valve replacement (TAVR), also called Transcatheter aortic valve implantation (TAVI), is a minimally invasive surgical procedure to treat aortic stenosis in high surgical risk patients. The global aortic stenosis market is estimated to be valued at US$ 8. The risk of aortic stenosis increases considerably with age and it is rarely seen in people younger than 60. SWOT Analysis Strength: The aortic stenosis market has a growing geriatric population who are more prone to aortic stenosis. Key Takeaways The global aortic stenosis market is expected to witness high growth over the forecast period of 2023 to 2030.

Aortic Stents Grafts Market Is Projected To Reach A Revised Size of US$ 4.5 Billion by 2031, Growing at a CAGR of 7.3%:

Harrykons 2023-04-26

The market report also computes the market size, market sales, revenue, price, market share and gross margin and market forecast, growth rate and cost structure. The global aortic stents grafts market in 2020 is estimated for more than US$ 2. In addition, the supportive reimbursement policies for endovascular repair surgeries with the high rate adoption of EVAR procedures also positively impacts the market growth. On the other note, lack of healthcare experts is likely to hamper the market growth. It includes the company evaluation quadrant for 25 major market players.

WHO TO FOLLOW